23 July 2026 FDA committee update: what changed for BPC-157
So for the purpose of this article, and with the intention of hoping to highlight what I see as massive gray areas in the discourse, Im going to define the moral sin of doping as: The use, accidental or on purpose, of a substance with a substantial evidentiary basis that it improves performance If youre going to write this off because hes just making up definitions for his own purposes, I hope you will keep reading because I aim to explain why this clearer definition of the term will serve to add to the discussion without further inflaming what I view as extreme views on both sides of this issue
TRT is more direct for replacing testosterone
BPC-157's documented effects on tendon, ligament, and muscle healing in preclinical models make it a compound of interest for patients who are placing new demands on connective tissues as their body composition changes
They show promising results in animal studies, but human evidence is limited, so we cannot confirm real clinical benefit
However, the company that makes Ozempic, Novo Nordisk, does not sell semaglutide for compounding, raising concerns about where compounded semaglutide comes from and the possible use of different formulas